CMS Removes Non-Invasive Ventilators From Round 2021 Of The Competitive Bidding Program

Published in Member Communities on April 10, 2020

CMS announced today that due to the novel COVID-19 pandemic, the Centers for Medicare & Medicaid Services (CMS) is removing the non-invasive ventilators (NIV) product category from Round 2021 of the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program. This was the first time that NIVs were included in the Competitive Bidding Program.

Clint Geffert, President of VGM & Associates, commented on the announcement saying, "This is a great start and gets us headed in the right direction. Removing NIVs from the Competitive Bidding Program helps maintain access to critical, complex equipment. DME suppliers can now have peace of mind as they navigate this PHE and beyond. Thank you to everyone and their efforts over the past year to help make this happen. This was a team effort as an industry united together to listen to all of our members' needs."

Click here to read the announcement.

From Our Experts

What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers thumbnail What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers Read what the proposed Numotion/Hanger merger could mean for CRT and O&P providers from VGM's SVP of Membership, Tyler Mahncke. What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers thumbnail What the Numotion/Hanger Merger Could Mean for CRT and O&P Providers Read what the proposed Numotion/Hanger merger could mean for CRT and O&P providers from VGM's SVP of Membership, Tyler Mahncke. Turning Unmet OSA Need Into Measurable Referral Growth thumbnail Turning Unmet OSA Need Into Measurable Referral Growth Discover strategies for HME providers to convert undiagnosed OSA into referral growth by enhancing PCP relationships and improving patient care outcomes. Turning Unmet OSA Need Into Measurable Referral Growth thumbnail Turning Unmet OSA Need Into Measurable Referral Growth Discover strategies for HME providers to convert undiagnosed OSA into referral growth by enhancing PCP relationships and improving patient care outcomes. Before You Add a New Product Line, Ask These Seven Questions thumbnail Before You Add a New Product Line, Ask These Seven Questions Explore the key reimbursement, accreditation, compliance, and operational considerations DMEPOS providers should evaluate before expanding services. A Pattern We're Seeing Across Healthcare thumbnail A Pattern We're Seeing Across Healthcare Insights on how healthcare providers can build trust, clarity, & confidence for patients, referral sources, & employees while navigating industry complexity. Medicare DMEPOS Compliance Updates: New F2F, WOPD, & Prior Authorization Requirements thumbnail Medicare DMEPOS Compliance Updates: New F2F, WOPD, & Prior Authorization Requirements Medicare is expanding DMEPOS compliance requirements, with new Face-to-Face (F2F), Written Order Prior to Delivery (WOPD), and Prior Authorization rules taking effect in 2026 and 2027. What AI and Industry Leaders Predict for HME's Future thumbnail What AI and Industry Leaders Predict for HME's Future Discover why HME growth remains strong despite reimbursement uncertainty, increased audits, staffing challenges, and operational pressures.